Pulmonary Congestion
10
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
Oxygen Targets in Acute Heart Failure With Pulmonary Congestion
Cardiometry in Hypotensive and Pumonary Congestion
LUS in Aortic Stenosis Patients Undergoing TAVR
LUS in Acute Heart Failure Therapeutic Adaptation
Fluid Restriction in Patients With Heart Failure
Utility of Lung Ultrasound in the Estimation of Extravascular Lung Water in Pediatric Population
Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance
Fluid Status of Outpatients With Dyspnea
Precision of IMED-4 Lung Fluid Measurements